These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8557879

  • 21. Safe use of imipenem/cilastatin in a neonatal intensive care unit.
    Lee SY, Chow CB.
    Acta Paediatr Jpn; 1998 Apr; 40(2):186-7. PubMed ID: 9581316
    [No Abstract] [Full Text] [Related]

  • 22. Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections.
    Uhari M, Seppänen J, Heikkinen E.
    Pediatr Infect Dis J; 1992 Jun; 11(6):445-50. PubMed ID: 1608680
    [Abstract] [Full Text] [Related]

  • 23. [Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)].
    Figuera A, Rivero N, Pajuelo F, Font P, Leyra F, de La Cámara R, Arranz R, María Fernández Rañada J.
    Med Clin (Barc); 2001 May 05; 116(16):610-1. PubMed ID: 11412645
    [Abstract] [Full Text] [Related]

  • 24. [Pharmacokinetic and clinical studies with imipenem/cilastatin sodium in neonates].
    Sato H, Narita A, Matsumoto K, Suzuki H, Nakazawa S, Nakanishi Y, Nakazawa S, Chikaoka H, Koido R, Kamigaki M.
    Jpn J Antibiot; 1988 Nov 05; 41(11):1657-70. PubMed ID: 3210300
    [Abstract] [Full Text] [Related]

  • 25. Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury.
    Hashimoto S, Wolfe E, Guglielmo B, Shanks R, Sundelof J, Pittet JF, Thomas E, Wiener-Kronish J.
    J Antimicrob Chemother; 1996 Nov 05; 38(5):809-18. PubMed ID: 8961050
    [Abstract] [Full Text] [Related]

  • 26. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
    de Groot HG, Hustinx PA, Lampe AS, Oosterwijk WM.
    J Antimicrob Chemother; 1993 Sep 05; 32(3):491-500. PubMed ID: 8262872
    [Abstract] [Full Text] [Related]

  • 27. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
    Eklund AE, Nord CE.
    J Antimicrob Chemother; 1993 Jan 05; 31 Suppl A():79-85. PubMed ID: 8383657
    [Abstract] [Full Text] [Related]

  • 28. Penetration of imipenem-cilastatin into the lung tissue and pericardial fluid of thoracotomized patients.
    Benoni G, Cuzzolin L, Bertrand C, Pucchetti V, Velo G.
    Chemioterapia; 1987 Jun 05; 6(2 Suppl):259-60. PubMed ID: 3509404
    [No Abstract] [Full Text] [Related]

  • 29. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus.
    Asensi F, Pérez-Tamarit D, Otero MC, Gallego M, Llanes S, Abadia C, Cantó E.
    Pediatr Infect Dis J; 1989 Dec 05; 8(12):895. PubMed ID: 2626294
    [No Abstract] [Full Text] [Related]

  • 30. Beneficial herb-drug interaction of rhein in Jinhongtang and Imipenem/Cilastatin mediated by organic anion transporters.
    Wu F, Zhao T, Zhang Y, Wang Y, Liao G, Zhang B, Wang C, Tian X, Feng L, Fang B, Huo X, Ma X.
    J Ethnopharmacol; 2023 Aug 10; 312():116449. PubMed ID: 37023835
    [Abstract] [Full Text] [Related]

  • 31. [Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in the perinatal period. A study of imipenem/cilastatin sodium in the perinatal co-research group].
    Matsuda S, Suzuki M, Oh K, Ishikawa M, Soma A, Takada H, Shimizu T, Makinoda S, Fujimoto S, Chimura T.
    Jpn J Antibiot; 1988 Nov 10; 41(11):1731-41. PubMed ID: 3062205
    [Abstract] [Full Text] [Related]

  • 32. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
    Singlas E.
    Presse Med; 1990 Apr 04; 19(13):598-605. PubMed ID: 2139939
    [Abstract] [Full Text] [Related]

  • 33. The penetration of imipenem/cilastatin into ascitic fluid in patients with chronic liver disease.
    Rolando N, Wade JJ, Philpott-Howard JN, Casewell MW, Williams R.
    J Antimicrob Chemother; 1994 Jan 04; 33(1):163-7. PubMed ID: 8157557
    [No Abstract] [Full Text] [Related]

  • 34. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL, Smith JW, Geckler RW, Wilson SE.
    South Med J; 1995 Apr 04; 88(4):397-404. PubMed ID: 7716590
    [Abstract] [Full Text] [Related]

  • 35. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Brismar B, Malmborg AS, Tunevall G, Lindgren V, Bergman L, Mentzing LO, Nyström PO, Anséhn S, Bäckstrand B, Skau T.
    J Antimicrob Chemother; 1995 Jan 04; 35(1):139-48. PubMed ID: 7768761
    [Abstract] [Full Text] [Related]

  • 36. [Fundamental and clinical evaluation of imipenem/cilastatin sodium in the perinatal period].
    Ito K, Izumi K, Takagi H, Tamaya T, Hayasaki M.
    Jpn J Antibiot; 1988 Nov 04; 41(11):1778-85. PubMed ID: 3210308
    [Abstract] [Full Text] [Related]

  • 37. Drugs recently released in Belgium. Torasemide, nalbuphine, imipenem-cilastatin.
    Harvengt C.
    Acta Clin Belg; 1987 Nov 04; 42(4):298-302. PubMed ID: 3270973
    [No Abstract] [Full Text] [Related]

  • 38. Worsening of myasthenia gravis on treatment with imipenem/cilastatin.
    O'Riordan J, Javed M, Doherty C, Hutchinson M.
    J Neurol Neurosurg Psychiatry; 1994 Mar 04; 57(3):383. PubMed ID: 8158196
    [No Abstract] [Full Text] [Related]

  • 39. [Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in neonates and premature infants].
    Toyonaga Y, Sugita M, Hori M, Joh K.
    Jpn J Antibiot; 1988 Nov 04; 41(11):1671-91. PubMed ID: 3210301
    [Abstract] [Full Text] [Related]

  • 40. Imipenem/cilastatin in the treatment of CAPD peritonitis.
    De Vecchi AF.
    Am J Nephrol; 1995 Nov 04; 15(2):180. PubMed ID: 7733161
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.